Cancer immunotherapy in Istanbul, Turkey
Immunotherapy is treatment that helps your own immune system fight cancer. Its main types — immune checkpoint inhibitors such as pembrolizumab and nivolumab, CAR T-cell and other T-cell transfer therapies, monoclonal antibodies, immune system modulators, and treatment vaccines — are all offered across Istanbul, often at JCI-accredited, state-authorized centers and well below Western-European prices for the same protocol. The honest catch is that it is not for everyone: biomarker testing such as PD-L1 and MSI status helps predict who benefits, so your tumour testing matters. Every price we show is an illustrative placeholder until verified partner-hospital quotes exist — and you pay the hospital directly, never us. Start with a free 72-hour review of your reports before you decide anything.
What immunotherapy is
The U.S. National Cancer Institute describes cancer immunotherapy as a type of treatment that helps your immune systemfight cancer. Because cancer cells can hide from or switch off the immune response, these treatments work by making it easier for the immune system to find and destroy cancer cells — either by taking the brakes off immune cells or by giving the body components, such as engineered cells or antibodies, that boost the attack. It is a distinct approach from chemotherapy, which targets fast-dividing cells directly.
The NCI is candid that immunotherapy is not yet as widely used as surgery, chemotherapy or radiation, that it is approved for many but not all cancers, and that it works better for some cancers than others. It can also cause immune-related side effects when the activated immune system attacks healthy tissue, which need monitoring. Crucially, biomarker testing helps predict who is likely to benefit, so it is not a treatment everyone should expect. Browse the wider cancer types hub for the diagnoses where it is used.
Treatment options
The types of immunotherapy the NCI lists, and an honest note on each:
- Immune checkpoint inhibitors. Drugs that block checkpoint proteins — PD-1, PD-L1 or CTLA-4 — so immune cells respond more strongly, such as pembrolizumab, nivolumab, ipilimumab and atezolizumab. Whether one applies usually depends on PD-L1 or MSI testing, not a template, and cost scales per cycle.
- T-cell transfer therapy. Treatments that boost your own T cells’ ability to fight cancer, including CAR T-cell therapy. These are highly specialized, used mainly for certain blood cancers, and available only at authorized programs — verify one directly.
- Monoclonal antibodies. Immune-system proteins made in the lab that bind specific targets on cancer cells; some mark cells for the immune system, and some overlap with targeted therapy. Which, if any, fits depends on your tumour’s markers.
- Immune modulators & treatment vaccines. Immune system modulators (such as cytokines or BCG) enhance the body’s response, and cancer treatment vaccines prompt the immune system to act against cancer. Their use is specific to particular cancers and situations.
See how these and other modalities work in general on the treatments & technology hub.
What it costs
There is no single immunotherapy price, because the cost is driven by which drug is used, how many cycles you receive, and how long treatment continues— immunotherapy is priced per cycle and the drug itself usually dominates the total, on top of biomarker testing, infusion visits and monitoring for immune-related side effects. Every figure OncologyIstanbul™ publishes today is an illustrative placeholder pending verified partner-hospital quotes, and each is itemized so you can hold a real quote up against it line by line. You pay the hospital directly, never us. See the Turkey Oncology Price Index or the full cancer treatment cost in Turkey breakdown.
The hospital, verified
We don’t show a wall of smiling oncologists or a “ranked” list — those are the easiest things to fabricate. Instead, you’re matched to one state-authorized Istanbul partner hospital whose medical-oncology subspecialty fits your diagnosis, and you can verify its authorization against the Republic of Turkey Ministry of Health’s own records and its JCI accreditation in JCI’s public directory before you commit. Named specialist profiles appear only when a verified, consented physician is behind the name. See the full guide to cancer hospitals in Istanbul and how to check one yourself.
Where this fits
This is one treatment approach within the broader cancer treatment in Istanbul pillar, and it is often used alongside surgery, chemotherapy or radiation rather than on its own. If you want your own reports read first, a free second opinion organizes and verifies your pathology, imaging and biomarker testing into a plain-language case file in your language before you decide whether to travel.
Related treatments & diagnostics
Check everything here — us included
Common questions
Can I get immunotherapy in Turkey?
Yes, for the tumour types and situations where it is established. Istanbul hospitals provide the immunotherapy pathways the U.S. National Cancer Institute describes — immune checkpoint inhibitors such as pembrolizumab, nivolumab, ipilimumab and atezolizumab, monoclonal antibodies, immune system modulators, and treatment vaccines — and some authorized programs handle T-cell transfer therapies. Many centers hold JCI accreditation and Turkish Ministry of Health state authorization, both of which you can check yourself before you commit. Immunotherapy is not right for everyone, though, so the honest first step is a free case review of your pathology, imaging and any biomarker testing before you travel or decide anything.
Which cancers does immunotherapy treat?
The NCI notes that immunotherapy is approved for many types of cancer but is not yet as widely used as surgery, chemotherapy or radiation, and that it works better for some cancers than others. Checkpoint inhibitors are used across a growing list including melanoma, lung, kidney, bladder and head-and-neck cancers and MSI-high tumours anywhere in the body; CAR T-cell therapy is used mainly for certain blood cancers. Whether immunotherapy fits your case depends on your exact diagnosis and tumour testing, not a template, and is a decision for a treating oncologist — this is general information, not a treatment recommendation.
Do I need PD-L1 or MSI testing first?
Often, yes. The NCI explains that biomarker testing helps predict who is likely to benefit from immunotherapy, because it does not work for everyone. Tumours are commonly tested for PD-L1 expression, for MSI-high / mismatch-repair-deficient (dMMR) status, and sometimes for tumour mutational burden — results that can point toward or away from a checkpoint inhibitor. This testing is usually done on the tumour tissue already taken at biopsy or surgery, so it may already exist on your reports. A free case review will flag whether it has been done and what it shows, before anyone discusses whether immunotherapy applies to you.
How much does immunotherapy cost in Istanbul?
There is no single figure, because immunotherapy is priced per cycle and the total is driven by which drug is used, how many cycles you receive, and how long treatment continues — the drug itself usually dominates the cost, on top of any biomarker testing, infusion visits and monitoring for immune-related side effects. Istanbul typically runs well below Western-European prices for the same protocol, but every figure OncologyIstanbul™ publishes today is an illustrative placeholder pending verified partner-hospital quotes, itemized so you can check a real written quote line by line. You pay the hospital directly, never us. See the Turkey Oncology Price Index for current ranges.
Start with a free 72-hour case review
Send your pathology, imaging and any biomarker testing. Get a verified case file in your language — free, confidential, no obligation.
This page is general information, not medical advice. Medical facts are grounded in the U.S. National Cancer Institute; prices shown are illustrative placeholders pending verified partner-hospital quotes, not offers. Every cancer case is individual; whether immunotherapy applies is a decision for a treating oncologist, and assessments are based on the reports you provide and do not replace in-person examination.